Review Article

Biomarker-Driven Targeted Therapies in Solid Tumor Malignancies

Hanjie Mo, PharmD, BCOP; Catherine Renna, PharmD, BCOP

Overcoming Resistance: Antibiotic Guidance for Multidrug-Resistant Febrile Neutropenia in Patients with Cancer

Sonya K. Kedzior, PharmD; YoungYoon Ham, PharmD; Joseph Bubalo, PharmD, BCOP, BCPS

Chemotherapy Administration Sequencing: An Update on the Current Literature

Alanna D. Lehman, PharmD, BCOP; Anna Howard, PharmD, BCOP; Robert Mancini, PharmD, BCOP

Review of Biosimilars and Their Potential Use in Oncology Treatment and Supportive Care in the United States

Whitney L. Pittman, PharmD; Christina Wern, PharmD; Ashley E. Glode, PharmD, BCOP

Targeting FLT3 and KIT Mutations in AML with Midostaurin: Implications for Clinicians and Pharmacists

Cory Bivona, PharmD, BCOP; Rachel Elsey, PharmD, BCOP; Casey Williams, PharmD, BCOP, FHOPA

Blinatumomab: A Step Forward in the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia

Lauren Drawdy, PharmD; Lee Ann Jones, PharmD, MBA; Philip D. Hall, PharmD, FCCP, BCPS, BCOP

Olanzapine for Prevention or Management of Chemotherapy-Induced Nausea and Vomiting: A Promising Option

Osama Al-Quteimat, MSc, BCOP; Jeffrey Tollison, RPh, BSPharm, BCPS; Mohammad Aslam Siddiqui, PharmD, MBA, CPHIMS

Current Treatment Options for Metastatic Renal-Cell Carcinoma: Review of the Literature

Pembrolizumab for Recurrent Metastatic Melanoma: Review of Current Use and Future Implications

Results 1 - 9 of 9

Copyright © Green Hill Healthcare Communications, LLC. All rights reserved.